Wolff Wiese Magana’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.36K Hold
78
﹤0.01% 630
2026
Q1
$5.85K Hold
78
﹤0.01% 572
2025
Q4
$6.09K Buy
78
+7
+10% +$568 ﹤0.01% 543
2025
Q3
$6.03K Hold
71
﹤0.01% 556
2025
Q2
$5.55K Buy
71
+28
+65% +$2.06K ﹤0.01% 541
2025
Q1
$3.11K Hold
43
﹤0.01% 656
2024
Q4
$3.81K Hold
43
﹤0.01% 603
2024
Q3
$3.64K Hold
43
﹤0.01% 634
2024
Q2
$3.98K Hold
43
﹤0.01% 453
2024
Q1
$4.85K Hold
43
﹤0.01% 399
2023
Q4
$4.01K Hold
43
﹤0.01% 405
2023
Q3
$3.94K Hold
43
﹤0.01% 467
2023
Q2
$5.22K Buy
+43
New +$4.64K ﹤0.01% 436
2022
Q4
Sell
-263
Closed -$20K 975
2022
Q3
$20K Hold
263
0.02% 373
2022
Q2
$29K Sell
263
-6
-2% -$637 0.02% 338
2022
Q1
$27K Hold
269
0.02% 365
2021
Q4
$26K Sell
269
-25
-9% -$2.51K 0.02% 384
2021
Q3
$33K Hold
294
0.02% 339
2021
Q2
$34K Buy
294
+3
+1% +$345 0.02% 330
2021
Q1
$30K Hold
291
0.02% 342
2020
Q4
$35K Buy
+291
New +$29.4K 0.03% 309

Other funds holding USPH

Wolff Wiese Magana's USPH Position: Q2 2026 in Review

Wolff Wiese Magana held its US Physical Therapy (USPH) position steady in Q2 2026 at 78 shares worth $5.36K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Wolff Wiese Magana first reported a position in USPH in Q4 2020 and has held it in 21 quarters since. The position peaked at $35K in Q4 2020. 50 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Wolff Wiese Magana held 78 shares of US Physical Therapy worth $5.36K as of Q2 2026.
  • Wolff Wiese Magana left its US Physical Therapy share count unchanged in Q2 2026.
  • US Physical Therapy made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #630 holding.
  • Wolff Wiese Magana first reported a position in US Physical Therapy in Q4 2020 and has held it in 21 quarters since.
  • Wolff Wiese Magana's US Physical Therapy position peaked at $35K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.